These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19212648)

  • 1. Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats.
    Ueno T; Fukuda N; Nagase H; Tsunemi A; Tahira K; Matsumoto T; Hiraoka-Yamamoto J; Ikeda K; Mitsumata M; Sato Y; Soma M; Matsumoto K; Yamori Y
    Int J Mol Med; 2009 Mar; 23(3):313-20. PubMed ID: 19212648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)/IzmDmcr rats as a new model of metabolic syndrome.
    Ueno T; Takagi H; Fukuda N; Takahashi A; Yao EH; Mitsumata M; Hiraoka-Yamamoto J; Ikeda K; Matsumoto K; Yamori Y
    Hypertens Res; 2008 May; 31(5):1021-31. PubMed ID: 18712058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cardiac size and function in SHRSP.Z-Lepr(fa)/IzmDmcr rats, a new animal model of metabolic syndrome.
    Tada Y; Kagota S; Matsumoto M; Naito Y; Shibata H; Nejime N; Tsujino T; Koshiba M; Masuyama T; Shinozuka K
    Biol Pharm Bull; 2010; 33(12):1971-6. PubMed ID: 21139235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotective mechanisms of telmisartan on renal injury and inflammation in SHRSP.Z-Leprfa/IzmDmcr rats.
    Sugiyama F; Kobayashi N; Ishikawa M; Onoda S; Ishimitsu T
    Clin Exp Nephrol; 2013 Aug; 17(4):515-24. PubMed ID: 23268284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of fatty acid profile in the liver of SHR/NDmcr-cp (cp/cp) rats, a model of the metabolic syndrome.
    Tanaka S; Yagi Y; Yamazaki T; Mitsumoto A; Kobayashi D; Kudo N; Kawashima Y
    Biol Pharm Bull; 2012; 35(2):184-91. PubMed ID: 22293348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome.
    Kagota S; Tada Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Can J Physiol Pharmacol; 2011 May; 89(5):355-64. PubMed ID: 21619437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats.
    Hiraoka-Yamamoto J; Nara Y; Yasui N; Onobayashi Y; Tsuchikura S; Ikeda K
    Clin Exp Pharmacol Physiol; 2004; 31(1-2):107-9. PubMed ID: 14756693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Dependent Differences in the Influence of Perivascular Adipose Tissue on Vasomotor Functions in Metabolic Syndrome.
    Kagota S; Iwata S; Maruyama K; McGuire JJ; Shinozuka K
    Metab Syndr Relat Disord; 2017 Jun; 15(5):233-239. PubMed ID: 28358621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal amounts of intracellular calcium regulatory proteins in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome and cardiac dysfunction.
    Kagota S; Maruyama K; Tada Y; Wakuda H; Nakamura K; Kunitomo M; Shinozuka K
    Can J Physiol Pharmacol; 2013 Feb; 91(2):124-33. PubMed ID: 23458196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Squalene Epoxidase and Higher Scavenger Receptor Class B Type 1 Protein Levels Are Involved in Reduced Serum Cholesterol Levels in Stroke-Prone Spontaneously Hypertensive Rats.
    Michihara A; Mido M; Matsuoka H; Mizutani Y
    Biol Pharm Bull; 2015; 38(12):1879-90. PubMed ID: 26632180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High susceptibility of obese hypertensive SHRSP.Z-Lepr(fa) /IzmDmcr rats to lipid deposition in the mesenteric artery.
    Kunimasa K; Yoshitomi H; Miura C; Mori H; Tsuchikura S; Ikeda K; Gao M; Yamori Y; Mori M
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1102-4. PubMed ID: 20726991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered fatty acid profile in the liver and serum of stroke-prone spontaneously hypertensive rats: reduced proportion of cis-vaccenic acid.
    Tanaka S; Kojiguchi C; Yamazaki T; Mitsumoto A; Kobayashi D; Kudo N; Kawashima Y
    J Oleo Sci; 2013; 62(11):933-48. PubMed ID: 24200942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review.
    Feng X; Zhang L; Xu S; Shen AZ
    Prog Lipid Res; 2020 Jan; 77():101006. PubMed ID: 31499095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic effects of a fructose diet in the stroke-prone spontaneously hypertensive rat.
    Brosnan MJ; Carkner RD
    Am J Hypertens; 2008 Jun; 21(6):708-14. PubMed ID: 18437120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
    Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats.
    Ogawa H; Okada Y; Kamisako T; Baba K
    Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):238-43. PubMed ID: 17250645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary phytosterols and phytostanols alter the expression of sterol-regulatory genes in SHRSP and WKY inbred rats.
    Chen Q; Gruber H; Pakenham C; Ratnayake WM; Scoggan KA
    Ann Nutr Metab; 2009; 55(4):341-50. PubMed ID: 19851062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome.
    Kagota S; Fukushima K; Umetani K; Tada Y; Nejime N; Nakamura K; Mori H; Sugimura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1035-43. PubMed ID: 20659132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats.
    Maruyama K; Kagota S; McGuire JJ; Wakuda H; Yoshikawa N; Nakamura K; Shinozuka K
    J Vasc Res; 2015; 52(4):232-43. PubMed ID: 26760532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.